GPATCH3 negatively regulates RLR-mediated innate antiviral responses by disrupting the assembly of VISA signalosome

Upon viral infection, retinoic acid-inducible gene I-like receptors (RLRs) recognize viral RNA and trigger a series of signaling events, leading to the induction of type I interferons (IFNs). These processes are delicately regulated to prevent excessive and harmful immune responses. In this study, w...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 13; no. 4; p. e1006328
Main Authors Nie, Ying, Ran, Yong, Zhang, Hong-Yan, Huang, Zhe-Fu, Pan, Zhao-Yi, Wang, Su-Yun, Wang, Yan-Yi
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.04.2017
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Upon viral infection, retinoic acid-inducible gene I-like receptors (RLRs) recognize viral RNA and trigger a series of signaling events, leading to the induction of type I interferons (IFNs). These processes are delicately regulated to prevent excessive and harmful immune responses. In this study, we identified G patch domain-containing protein 3 (GPATCH3) as a negative regulator of RLR-mediated antiviral signaling pathways. Overexpression of GPATCH3 impaired RNA virus- triggered induction of downstream antiviral genes, whereas its knockdown had opposite effects and attenuated viral replication. In addition, GPATCH3-deficient cells had higher IFNB1 mRNA level compared with control cells after RNA virus infection. Mechanistically, GPATCH3 was recruited to VISA in a viral infection dependent manner and the assembly of VISA/TRAF6/TBK1 signalosome was impaired in GPATCH3-overexpressing cells. In contrast, upon viral infection, the recruitment of TRAF6 and TBK1 to VISA was enhanced in GPATCH3 deficient cells. Taking together, our findings demonstrate that GPATCH3 interacts with VISA and disrupts the assembly of virus-induced VISA signalosome therefore acts as a negative regulator of RLR-mediated innate antiviral immune responses.
Bibliography:new_version
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors have declared that no competing interests exist.
Conceptualization: YYW.Data curation: YN.Formal analysis: YN YYW.Funding acquisition: YYW.Investigation: YN YR HYZ ZFH ZYP SYW.Methodology: YN YYW.Project administration: SYW YYW.Supervision: YYW.Validation: YN YR HYZ.Visualization: YN YYW.Writing – original draft: YN YYW.Writing – review & editing: YN YYW.
ISSN:1553-7374
1553-7366
1553-7374
DOI:10.1371/journal.ppat.1006328